SCHEMBL13222736

SCHEMBL13222736

COc1ccc(C2(OCO)CC2)cc1CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.39
PDE4A P27815 3/20 0.39
PDE4B Q07343 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
CASP1 P29466 2/20 0.36
GAA P10253 1/20 0.36
SLC5A1 P13866 1/20 0.36
SLC5A2 P31639 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
MCL1 Q07820 1/20 0.33
ALOX12 P18054 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
POLA1 P09884 2/20 0.33
PDE5A O76074 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE3B Q13370 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13222737 0.83 ALOX15 (0.38) ALOX15CASP1GAALMNATSHR
SCHEMBL721997 0.78 ALOX15 (0.41) ALOX15PDE4APDE4BPDE4CPDE4D
SCHEMBL13222774 0.75 BCHE (0.51) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL12170294 0.75 LMNA (0.47) ALOX15PDE4APDE4BPDE4CPDE4D
SCHEMBL1465608 0.75 TLR7 (0.49) PDE4DLMNA
SCHEMBL1465313 0.74 LMNA (0.46) ALOX15CASP1LMNATSHR
SCHEMBL10282955 0.71 LMNA (0.44) ALOX15PDE4APDE4BPDE4CPDE4D
SCHEMBL2908313 0.68 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DGAA
SCHEMBL1742531 0.68 PDE4A (0.50) ALOX15PDE4APDE4BPDE4CPDE4D
SCHEMBL487944 0.68 HSD17B10 (0.62) PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776905-B2 including Cystic Fibrosis Transmembrane Conductance Regulator (\"CFTR\"), such as 1-(Benzo[d][1,3]dioxol-5-yl)-N-(2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, used for the treatment of genetic disorders such as cystic fibrosis, emphysema, hemochromatosis and protein C deficiency VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-08-17 US disclosed